Klingmann I

No ORCID on file · 1 paper in corpus · active 2020
2020
Efficacy, safety and tolerability of progesterone vaginal pessaries versus progesterone vaginal gel for luteal phase support after in vitro fertilisation: a randomised controlled trial.
Human reproduction (Oxford, England) ·doi:10.1093/humrep/dez261

Study questionAre progesterone vaginal pessaries 400 mg twice a day (bid) non-inferior to progesterone vaginal gel (90 mg) once a day (od) in the primary endpoint of clinical pregnancy rate after 38 days of luteal phase support in women und…